Monitor future Form 4 filings for actual option exercises or stock sales, which could signal insider sentiment. No immediate trading implications from this routine disclosure.
Price Chart
Executive Summary
Paul Douglas Burgess, Chief Operating Officer & Chief Business Officer of Kailera Therapeutics, filed a Form 3 disclosing initial beneficial ownership of stock options and appointed attorneys-in-fact to handle future SEC filings on his behalf. This is a routine regulatory filing related to insider ownership.
Key Facts
- Paul Douglas Burgess filed Form 3 as initial statement of beneficial ownership.
- He holds three tranches of stock options with exercise prices ranging from $5.25 to $7.24, vesting between 2025 and 2026.
- Options cover a total of 802,242 shares of common stock.
- Burgess appointed three individuals as attorneys-in-fact to file SEC reports on his behalf under Rule 16 and Form 144.
- The filing is standard for new executive insiders and does not indicate any immediate transactions or changes in control.
Financial Impact
No immediate financial impact; options represent future potential dilution of approximately 802,242 shares if fully exercised.
Risk Factors
- Potential for future insider selling once options vest and are exercised.
- Increased share dilution if all options are exercised.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159694 |
| Document: 0001193125-26-159694-index-headers.html | 0001193125-26-159694 |
| Document: 0001193125-26-159694-index.html | 0001193125-26-159694 |
| Document: 0001193125-26-159694.txt | 0001193125-26-159694 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access